Page breadcrumb nav

VAERS Report 2157167

Case Report Section

Vaer Report Details

Age: NA

Gender: Female

State: Outside US

Patient Died?
No
Vaccine information

Name: COVID19 (COVID19 (JANSSEN))

Type: Coronavirus 2019 vaccine

Manufacturer: JANSSEN

Lot: unknown


Date report was received
2022-03-04
Date form completed
Date Vaccinated
2021-07-03
Date of Onset
3
Number of days (onset date – vaccination date)
3
Adverse Event Description

bleeding breakthrough; irregular periods; menstrual cycle abnormal; this spontaneous report received from a consumer via a regulatory authority (ie-hpra-2022-093024) on 02-mar-2022 and concerned a 34 year old female of unspecified race and ethnicity. the patient's weight was 63.106 kilograms, and height was not reported. no past medical history or concurrent conditions were reported. the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total (first dose), administered on 03-jul-2021 for covid-19 immunisation. the batch number was not reported. the company is unable to perform follow-up to request batch/lot numbers. drug start period was 3 days. no concomitant medications were reported. on 06-jul-2021, the patient experienced bleeding breakthrough, irregular periods, and menstrual cycle abnormal. the action taken with covid-19 vaccine ad26.cov2.s was not applicable. the patient recovered from bleeding breakthrough, irregular periods, and menstrual cycle abnormal. this report was serious (other medically important condition)

Lab Data
na
List of symptoms
menstruation irregular menstrual disorder intermenstrual bleeding
Patient Died?
No
Date Died
NA
Birth defect
false
Vaccine Administered By:
Other
Vaccine Purchased By:
Unknown
Patient visit ER?
No
Patient Hospitalized?
No
Stay in hospital
No
Days in hospital
Unspecified
Permanent disability?
No
Allergies:
na
Current Illness
na